about
Medical treatment of early stage and rare histological variants of epithelial ovarian cancerReproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies.Fertility preservation in women with borderline ovarian tumours.3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3).Clinical implications of the heterogeneity of hematopoietic progenitors elicited in peripheral blood by anticancer therapy with cyclophosphamide and cytokine(s).The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo Osseo.Rituximab in Hodgkin lymphoma: is the target always a hit?Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials.Risk of thrombosis in women with malignancies undergoing ovarian stimulation for fertility preservation.RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy.Difficult choices for young patients with cancer: the supportive role of decisional counseling.Intensified ChlVPP/ABVVP chemotherapy regimen and pegfilgrastim support in advanced Hodgkin lymphomaEfficacy of vinblastine, bleomycin, methotrexate (VBM) combination chemotherapy with involved field radiotherapy in early stage (I-IIA) Hodgkin disease patients.Optimizing the use of epidermal growth factor receptor inhibitors in advanced non-small-lung cancer (NSCLC)Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.Tongue cancer during pregnancy: Surgery and more, a multidisciplinary challenge.Oocyte cryopreservation beyond cancer: tools for ethical reflection.Chronic lymphocytic leukaemia during pregnancy: management and thoughtsPrognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study.Expression of CD3-zeta on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodesBreast cancer in young women - Special Issue.Breast-feeding after breast cancer: if you wish, madam.Lung cancer in the pregnant woman: to treat or not to treat, that is the question.Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumors.Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors.Breast cancer in pregnancy: recommendations of an international consensus meeting.Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies.Motherhood after breast cancer: searching for la dolce vita.Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: how should we counsel cancer patients about breastfeeding?Are monoclonal antibodies a safe treatment for cancer during pregnancy?First international consensus guidelines for breast cancer in young women (BCY1).Patient-centred management in idiopathic pulmonary fibrosis: similar themes in three communication models.Strategies for fertility preservation in young early breast cancer patients.Fertility preservation in cancer patients: the global framework.Treatment options for pregnant women with ovarian tumors.Targeted agents for cancer treatment during pregnancy.Discrepancies between ESMO and NCCN breast cancer guidelines: An appraisal.Frequency of Pregnancy Related Cancer: A Population Based Linkage Study in Lombardy, Italy.Exploring the safety of chemotherapy for treating breast cancer during pregnancy.Special issues in fertility preservation for gynecologic malignancies.
P50
Q26777702-DC6D5C6C-9F28-4346-94C0-0AF87347D6ADQ30248475-E62AAF48-1630-40D0-9DAA-9D00B6E8D95AQ30248932-3E378B77-9259-4B1A-9688-60D1C8954697Q30313649-AC6CA57D-8AAD-4969-9A6D-86C1F493C94FQ33492194-ED156A80-A89D-4C36-8B24-A843E79E2B15Q33755643-C1869F0C-19E6-485A-B320-CBDA6C0B83ADQ34156451-F1108395-C41E-4FDA-9A2C-43ADDB661CC1Q34393606-CA70A234-0C92-4F30-8FCA-6CE5E3079921Q34428728-607D094F-2A14-4EA8-971F-85031904F22AQ35218182-933ECB94-7ABC-4C05-939E-4F14EC156095Q35599419-3C8590F2-4100-4063-AB78-669ADFF9FB91Q35602142-02529BFF-810A-477C-83AD-48F0D2186A1DQ35635560-FAC28632-5213-4E16-8966-4283D9BEB814Q35667782-294FA3EE-DC2C-4E6B-8DD7-7ED73C259644Q35766397-2A6EE894-6199-4D25-9102-91C929F94762Q35811567-40F8E17B-805B-4D8B-93F3-AC810ED8E6F8Q36010222-FEDA52A5-3F30-427E-A08C-C58BAD3699A4Q36319427-3FD80C80-D19B-40E7-85B9-B1A6B2DEC597Q36490058-A6AB62B5-AEEB-4C5B-9F53-43FDAE909090Q36617463-B88AFCFD-1D3E-4F72-AFA6-5D3B8BF48A59Q36963350-050FF365-1402-4DC6-B33C-427E702C016AQ37121692-D94446A7-3876-4AC9-81B5-5035CB06DBB7Q37628981-E9040664-BDDC-4F47-A276-C38A6390BCB8Q37656611-006204BA-1666-4619-BD62-5B297D5029B1Q37657898-3C613655-4945-4896-B31C-57FC8C3C14B6Q37798893-381A922B-A25D-421A-919A-237ABECE3CE0Q37799895-05C6FA94-02D3-44F8-A7E6-9C5FE33538D7Q37845835-0292F7BF-FC3E-4B46-9F3C-C9B8B4322A1FQ38064048-97A09D41-6669-47BE-ABD0-708EDCD50177Q38119550-B3FB0F8E-0508-4B87-8403-3B047495DE16Q38207296-FE1F27C5-E051-4BDA-B440-7F941938D9E7Q38216399-BFDDF71B-15B6-48AD-BA7A-4CAEC712C650Q38220680-0C26E581-C646-4614-9DCA-B6B6C28C7354Q38222337-D5C36BC0-2DF7-4F78-A57D-68A576B16FE7Q38224630-A6716907-6EE8-4EF3-BF63-CAE72076C631Q38385800-E999B794-0B55-432D-9292-E0632A0BBB12Q38394423-AA419B79-6D8F-472D-B320-8FC57F2AED23Q38403248-800D0BC5-CCEB-4708-9B07-763F4546D716Q38539265-935320A3-5FF2-45A1-BFF4-043DF5BFC0E9Q38584439-617F98F4-22C8-4756-954A-53BCAA0EFC22
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fedro A Peccatori
@ast
Fedro A Peccatori
@en
Fedro A Peccatori
@es
Fedro A Peccatori
@it
Fedro A Peccatori
@nl
type
label
Fedro A Peccatori
@ast
Fedro A Peccatori
@en
Fedro A Peccatori
@es
Fedro A Peccatori
@it
Fedro A Peccatori
@nl
prefLabel
Fedro A Peccatori
@ast
Fedro A Peccatori
@en
Fedro A Peccatori
@es
Fedro A Peccatori
@it
Fedro A Peccatori
@nl
P214
P244
P268
P269
P5739
P106
P1153
7004514394
P1207
n2009046353
P213
0000 0001 1767 3875
P214
P244
nb2007027685
P268
P269
P31
P496
0000-0001-8227-8740
P5739
P7859
lccn-nb2007027685